BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6641616)

  • 21. Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats.
    Gardner EL; Schiffer WK; Horan BA; Highfield D; Dewey SL; Brodie JD; Ashby CR
    Synapse; 2002 Dec; 46(4):240-50. PubMed ID: 12373739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia with prominent catatonic features ('catatonic schizophrenia') III. Latent class analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Lee E; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):81-5. PubMed ID: 18992297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative motor activity differentiates schizophrenia subtypes.
    Walther S; Horn H; Razavi N; Koschorke P; Müller TJ; Strik W
    Neuropsychobiology; 2009; 60(2):80-6. PubMed ID: 19752582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics.
    Beckmann H; Fritze J; Franzek E
    Neuropsychobiology; 1992; 26(1-2):50-8. PubMed ID: 1361971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
    Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
    Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gamma-vinyl-GABA: first experiences in Italy. II].
    de Romanis F; Sopranzi N
    Clin Ter; 1994 Mar; 144(3):193-9. PubMed ID: 8181215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute psychosis and vigabatrin in childhood].
    Chiaretti A; Castorina M; Tortorolo L; Piastra M; Polidori G
    Pediatr Med Chir; 1994; 16(5):489-90. PubMed ID: 7885961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focus on vigabatrin. Proceedings of a satellite symposium. 17th Epilepsy International Congress. Jerusalem, Israel, 6-11th September, 1987.
    Br J Clin Pract Suppl; 1988 Mar; 61():1-41. PubMed ID: 3145768
    [No Abstract]   [Full Text] [Related]  

  • 31. [Review of the concept of personality deterioration in schizophrenia].
    Donnoli VF
    Acta Psiquiatr Psicol Am Lat; 1991 Mar; 37(1):37-45. PubMed ID: 1862715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
    Hatta K; Miyakawa K; Ota T; Usui C; Nakamura H; Arai H
    J ECT; 2007 Dec; 23(4):233-5. PubMed ID: 18090694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
    Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
    Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus.
    Qume M; Fowler LJ
    Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Schizophrenics prior to schizophrenia. Comparative and statistical inquiry on the infantile antecedents of 35 schizophrenics and 35 control subjects].
    Bourgeois M; Etchepare JJ
    Ann Med Psychol (Paris); 1986 Jul; 144(7):757-66. PubMed ID: 3827061
    [No Abstract]   [Full Text] [Related]  

  • 36. [The subjective experience in catatonia: systematic study of 24 catatonic patients].
    Northoff G; Krill W; Wenke J; Travers H; Pflug B
    Psychiatr Prax; 1996 Mar; 23(2):69-73. PubMed ID: 8657812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The place of pyrogen therapy in the modern treatment of schizophrenia patients].
    Malin DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):81-5. PubMed ID: 1332338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Decrease of catatonic schizophrenia in patients hospitalized in 1984 in comparison to 1964].
    Silva H; Jerez S; Catenacci M; Mascaro J
    Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):132-8. PubMed ID: 2640413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of gamma-vinyl GABA in Friedreich's ataxia.
    De Smet Y; Mear JY; Tell G; Schechter PH; Lhermitte F; Agid Y
    Can J Neurol Sci; 1982 May; 9(2):171-3. PubMed ID: 7104882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased mesolimbic GABA concentration blocks heroin self-administration in the rat.
    Xi ZX; Stein EA
    J Pharmacol Exp Ther; 2000 Aug; 294(2):613-9. PubMed ID: 10900239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.